Skip to content

FAQ'S

Multiple Myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell found in the bone marrow. In Multiple Myeloma, abnormal plasma cells, known as myeloma cells, multiply uncontrollably, crowding out healthy blood cells in the bone marrow.

Common symptoms of Multiple Myeloma include bone pain, weakness, fatigue, recurrent infections, and anemia. Other symptoms may include kidney problems, hypercalcemia (high calcium levels), and neurological symptoms.

Diagnosis of Multiple Myeloma typically involves blood tests, urine tests, bone marrow biopsy, imaging tests (such as X-rays, CT scans, or MRIs), and other laboratory tests to detect abnormal plasma cell levels and assess any bone damage or organ dysfunction
Treatment for Multiple Myeloma depends on various factors, including the stage of the disease, overall health, and individual preferences. Treatment options may include chemotherapy, targeted therapy, immunotherapy, stem cell transplantation, and radiation therapy.
Factors that influence the prognosis of Multiple Myeloma include the stage of the disease at diagnosis, the presence of certain genetic abnormalities, response to treatment, overall health and age of the patient, and any complications or comorbidities.